logo

GSK

GSK·NYSE
--
--(--)
--
--(--)

GSK fundamentals

GSK (GSK) Revenue Breakdown: Q4 2025 Business & Regional Performance
GSK (GSK) reported total revenue of 11.59B USD in Q4 2025, with its core business segment Specialty Medicines contributing 44.15%. Regionally, United States remained the largest market, accounting for 51.55% of total revenue. Explore GSK's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data